Arkolith/Insider Trading/INBX/Form 4

Manhard Kimberly

DirectorInhibrx Biosciences, Inc. (INBX) · full profile →Form 4 · filed Aug 30, 2024
Net Buying
Open-Market Buys
$140K
Open-Market Sells
$0
Net Open-Market Flow
$140K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 28, 2024Buy(P)10K$13.98$140K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002007919-24-000042) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML